Sepsis Pipeline Could Be Resuscitated With Narrower Trials, Researchers Propose
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Sepsis trials designed with narrower enrollment criteria could allow treatment effects to emerge, countering the “signal to noise” problem that has plagued late-stage trials in sepsis, researchers suggest.